Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

<p>Simvastatin responsive genes</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Gia-Buu Tran (16437051) (author)
Autres auteurs:	Jane Ding (16437054) (author), Bingwei Ye (16437057) (author), Mengling Liu (16437060) (author), Yajie Yu (16437063) (author), Yunhong Zha (16437066) (author), Zheng Dong (16437069) (author), Kebin Liu (14939874) (author), Sunil Sudarshan (16437072) (author), Han-Fei Ding (16437075) (author)
Publié:	2025
Sujets:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Drug Targets Metabolism Metabolic pathways Pediatric Cancers Small Molecule Agents
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
par: Gia-Buu Tran (16437051)
Publié: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
par: Gia-Buu Tran (16437051)
Publié: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
par: Gia-Buu Tran (16437051)
Publié: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
par: Gia-Buu Tran (16437051)
Publié: (2025)

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
par: Haowen Jiang (14963613)
Publié: (2025)

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
par: Haowen Jiang (14963613)
Publié: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
par: Haowen Jiang (14963613)
Publié: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
par: Haowen Jiang (14963613)
Publié: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
par: Snehanshu Chowdhury (14957031)
Publié: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
par: Pochung Jordan Chou (14851578)
Publié: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
par: Pochung Jordan Chou (14851578)
Publié: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
par: Pochung Jordan Chou (14851578)
Publié: (2025)

Supplementary Table 1 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
par: David Olayinka Kamson (16617218)
Publié: (2025)

Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
par: David Olayinka Kamson (16617218)
Publié: (2025)

Effects of <i>T. gondii</i> infection on rat gut microbiota diversity.
par: Ji-Xin Zhao (22056386)
Publié: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
par: William Kelly (15439117)
Publié: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
par: William Kelly (15439117)
Publié: (2025)

Table S1 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
par: Thomas Farge (15112135)
Publié: (2025)

Table S2 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
par: Thomas Farge (15112135)
Publié: (2025)

Table S3 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
par: Thomas Farge (15112135)
Publié: (2025)

Table S4 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
par: Thomas Farge (15112135)
Publié: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
par: Evangeline R. Jackson (15558808)
Publié: (2025)

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
par: Sebastian Johannes Schober (14971891)
Publié: (2025)

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
par: Sebastian Johannes Schober (14971891)
Publié: (2025)

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
par: Sebastian Johannes Schober (14971891)
Publié: (2025)

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
par: Sebastian Johannes Schober (14971891)
Publié: (2025)

Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
par: Sebastian Johannes Schober (14971891)
Publié: (2025)

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
par: Chun-Miao Deng (15618965)
Publié: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
par: Gwo Yaw Ho (14961416)
Publié: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
par: Laura Privitera (16015972)
Publié: (2025)

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
par: Elizabeth R. Tucker (15053624)
Publié: (2025)

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
par: Elizabeth R. Tucker (15053624)
Publié: (2025)

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
par: Elizabeth R. Tucker (15053624)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_m6sna8h1skd1kbpd68uj1b6ooe